Ependion has carried out a directed share issue

On 15 May 2025, Ependion AB completed a directed share issue of approximately SEK 300 million before transaction costs.

The subscription price corresponded to the closing price of the company’s share on Nasdaq Stockholm on 15 May 2025, and was determined through an accelerated book-building procedure directed at Swedish and international institutional investors.

Ependion will use the proceeds from the share issue to partially finance the initial purchase price for the acquisition of Welotec, which is expected to be completed during the second quarter of 2025.

Ependion was advised by Mannheimer Swartling in the share issue.

Cookies

This website uses cookies to perform certain functions and help you navigate the site efficiently. A cookie is a text file with a small amount of information that is stored on your device. We share some of the information we obtain through these cookies with third parties. We only use cookies that are necessary for the site to function correctly and they therefore cannot be turned off. For further information, see Information on the use of cookies.